Philadelphia, PA
Imagene AI provides AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy.
imagene-ai.comThese are collections Imagene AI is a part of. Click on the collection name to view similar companies.
Series B
$23,000,000
Seed
$3,000,000
Series A
$18,500,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Imagene AI.